by plexusventures_h3tnl0 | Feb 16, 2021 | Uncategorized
Milan and New York, 16/2/2021 – Healthware Group and Plexus Ventures have formed an alliance to structure deals for the pharmaceutical industry in the development and commercialization of DTx products. Given the increased attention and growth seen in the market, both...
by plexusventures_h3tnl0 | Jan 11, 2021 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Glenmark Pharmaceuticals. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal...
by plexusventures_h3tnl0 | Mar 1, 2020 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Olessia Kamp, based near Frankfurt, as Senior Advisor in Germany. Prior to joining Plexus, Olessia served for nearly 15 years at Berlin-Chemie AG, a subsidiary of Menarini, focusing from German...
by plexusventures_h3tnl0 | Sep 1, 2019 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Dr. Daniel Sieiro Mosti as Scientific Associate. Dr. Sieiro is a former research fellow at Harvard Medical School where he focused on the genetic basis of tissue development in health and...
Recent Comments